Acute pancreatitis is the most common and feared complication of endoscopic retrograde cholangiopancreatography (ERCP). It is associated with substantial morbidity and occasional mortality. The mechanisms that lead to post-ERCP pancreatitis are complex and not fully understood. Rather than having a single pathogenesis, post-ERCP pancreatitis is believed to be multi-factorial, involving a combin...

Post ERCP pancreatitis, also known as post-endoscopic retrograde cholangiopancreatography is a potentially serious complication that can occur after this endoscopic procedure. It characterized by acute inflammation of the pancreas, triggered manipulation and trauma induced during ERCP. This clinical condition manifests with severe abdominal pain, nausea, vomiting, bloating fever. varies in seve...

Endoscopic retrograde cholangiopancreatography (ERCP) was first introduced in 1968 and has been an effective tool in the diagnosis and treatment of biliary and pancreatic diseases [1,2]. The first ERCP in mainland China was performed in 1973 [3]. After four decades of development, ERCP services have been provided throughout China. However, a national survey showed that only 63787 ERCP procedure...

The most reliable indicators for post-ERCP acute pancreatitis are elevated amylase levels and abdominal pain 24 hours after ERCP. As ERCP is often performed on an outpatient basis, earlier diagnosis is important. We aimed to identify early predictors of post-ERCP pancreatitis. We prospectively analyzed IL-6, IL-10, TNFα, CRP, amylase and lipase before and 4 hours after ERCP, and studied their a...

BACKGROUND/AIMS The protease inhibitors, nafamostat and gabexate, have been used to prevent pancreatitis related to endoscopic retrograde cholangiopancreatography (ERCP). In vitro, nafamostat inhibits the pancreatic protease activities 10-100 times more potently than gabexate. We evaluated the efficacy of nafamostat for prophylaxis against post-ERCP pancreatitis in comparison with gabexate. M...

BACKGROUND/AIMS Acute pancreatitis is a common complication of endoscopic retrograde cholangiopancreatography (ERCP). Combination therapy w ith ora l udenafil and aceclofenac may reduce the occurrence of post-ERCP pancreatitis by targeting different pathophysiological mechanisms. We investigated whether combining udenafil and aceclofenac reduced the rates of post-ERCP pancreatitis. METHODS A ...

Endoscopic retrograde cholangiopancreatography (ERCP) is a therapeutic procedure used to treat problems associated with biliary and pancreatic diseases. The benefits of ERCP over surgical treatment are well documented; however, complications including infection, pancreatitis, hemorrhage, and perforation can occur even in expert hands. Several factors, such as patient selection, skill of the ope...

We present a rare complication of cardiac arrest from asystole in the setting of prolonged endoscopic retrograde cholangiopancreatography(ERCP) procedure. Cardiopulmonary complications of ERCP are rare but can be fatal. Therefore it is essential to closely monitor the patient during ERCP. Immediate access to resuscitation equipment facilitating prompt intervention in the unlikely event of fatal...

background: pancreatitis is most common complication of post-ercp and needs to admission at least for one day. the purpose of this study was to assess the efficacy of guide wire for better common bile duct (cbd) cannulation for reducing post-ercp pancreatitis. methods: from april 2010 through march 2011, the patients who needed ercp and referred to shahid beheshti and rouhani teaching hospital ...

background: juxta-ampullary diverticulum is an acquisitive disorder generally observed in patients over the age of forty years. the purpose of this study is to evaluate the relationship between this abnormality and the incidence of post-ercp complications. â  materials and methods: this was a case-control cross-sectional study that compared post- ercp complications between patients with juxta-a...